IL13 and asthma: For example, periostin and DPP-4 are being explored as potential predictors for IL-13-targeting biologics in asthma [89], while IL-33 and soluble IL-33R levels in sputum or serum may aid in selecting therapies that inhibit IL-33 signaling [91].